Clinical Trials Directory

Trials / Conditions / Metastatic Colorectal Cancer (mCRC)

Metastatic Colorectal Cancer (mCRC)

25 registered clinical trials studyying Metastatic Colorectal Cancer (mCRC) — 15 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingLPM6690176 in Combination With Chemotherapy and Bevacizumab in Metastatic Colorectal Cancer Patients With RAS
NCT07391566
Luye Pharma Group Ltd.Phase 1 / Phase 2
Not Yet RecruitingPhase II Basket Trial: Zanidatamab Plus Tislelizumab in HER2-Positive GI Tumors (UNION-HER2-BASKET)
NCT07243938
Tao ZhangPhase 2
RecruitingContinuation of Cetuximab Beyond First-Line Progression in Metastatic Colorectal Cancer
NCT07389265
University of Campania Luigi VanvitelliPhase 3
Not Yet RecruitingThe Study of JMT101 Combined With Irinotecan as a ≥3rd-Line Treatment in Metastatic Colorectal Cancer
NCT07134205
Shanghai JMT-Bio Inc.Phase 3
Not Yet RecruitingEvaluation of a Diagnostic Test to Identify the Best Drugs for Treatment of Metastatic Colorectal Cancer
NCT07171554
Oncosyne ASN/A
RecruitingThe Phase-2 CCR5-targeting Leronlimab With Oral Chemotherapy and VEGF-inhibitor Enriched Regimen Trial (CLOVER
NCT06699836
CytoDyn, Inc.Phase 2
RecruitingRandomized Controlled Trial of the Effects of Combined Resistance and AerobiC Exercise on Health-related Quali
NCT06938971
Rigshospitalet, DenmarkN/A
RecruitingA Clinical Study of Arfolitixorin in Patients With mCRC
NCT06922383
Isofol Medical ABPhase 1 / Phase 2
RecruitingEfficacy And Safety Of Hydroxychloroquine Combined With Methotrexate, Capecitabine And Bevacizumab Vs. Regoraf
NCT06949982
Sergey Orlov, MDPhase 2
RecruitingFruquintinib in Patients With Metastatic Colorectal Cancer
NCT06787105
iOMEDICO AG—
RecruitingA Clinical Trial Evaluating the Safety and Efficacy of Intravenous HNF4α SrRNA in Treating Metastatic CRC Pati
NCT06621173
Shanghai Changzheng HospitalEARLY_Phase 1
RecruitingAGMT Metastatic Colorectal Cancer Registry (mCRC) Third Line and Beyond
NCT06678919
Arbeitsgemeinschaft medikamentoese Tumortherapie—
UnknownA Study of JMT101 in Patients With Metastatic Colorectal Cancer
NCT06089330
Shanghai JMT-Bio Inc.Phase 2
RecruitingDHF-20-1839-2: Clinical Performance Study Protocol for Therascreen® KRAS RGQ PCR Kit
NCT06645236
QIAGEN Gaithersburg, IncN/A
RecruitingXELOX +Bev +Tislelizumab for First-line Treatment of MSS/pMMR RAS-mutated mCRC
NCT05970302
Cancer Institute and Hospital, Chinese Academy of Medical SciencesPhase 2
CompletedAn Observational Study Called STAR-T to Learn More About the Sequential Treatment With Regorafenib and TAS-102
NCT05839951
Bayer—
RecruitingPDS01ADC in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metast
NCT05286814
National Cancer Institute (NCI)Phase 2
TerminatedA Clinical Studyf of SHR-1701 or Placebo in Combination With BP102 and XELOX in the First-line Treatment of mC
NCT04856787
Suzhou Suncadia Biopharmaceuticals Co., Ltd.Phase 2 / Phase 3
Active Not RecruitingAssessing a Regorafenib-irinotecan Combination Versus Regorafenib Alone in Metastatic Colorectal Cancer Patien
NCT03829462
Institut du Cancer de Montpellier - Val d'AurellePhase 3
CompletedA Study of Overall Survival in Participants With Metastatic Colorectal Cancer (mCRC)
NCT05420909
Bristol-Myers Squibb—
CompletedA Clinical Study to Compare the Efficacy, Safety and Immunogenicity of HLX04 and Bevacizumab Combined XELOX or
NCT03511963
Shanghai Henlius BiotechPhase 3
CompletedStudy of the Safety, Tolerability and Efficacy of KPT-8602 in Participants With Relapsed/Refractory Cancer Ind
NCT02649790
Karyopharm Therapeutics IncPhase 1 / Phase 2
CompletedBioequivalence Study Bevacizumab Biosimilar (BEVZ92) Versus Bevacizumab (AVASTIN®) in First-line Treatment mCR
NCT02069704
mAbxience Research S.L.Phase 1
CompletedIntravenously Administered Pegylated Liposomal Mitomycin-C Lipid-based Prodrug (PROMITIL) in Cancer Patients W
NCT01705002
Lipomedix Pharmaceuticals Inc.Phase 1
CompletedPhase I/II Combination With Irinotecan- Erbitux
NCT00594984
Bristol-Myers SquibbPhase 1 / Phase 2